Application of a novel inhibitor of human CD59 for the enhancement of complement-dependent cytolysis on cancer cells

Por You, Tao, Hu, Weiguo, Ge, Xiaowen, Shen, Jingnan, Qin, Xuebin
Publicado em 2011

Deficiency of the Complement Regulatory Protein CD59 Accelerates the Development of Diabetes-induced Atherosclerosis in Mice

Por Liu, Fengming, Sahoo, Rupam, Ge, Xiaowen, Wu, Lin, Ghosh, Pamela, Qin, Xuebin, Halperin, Jose A.
Publicado no J Diabetes Complications (2016)

rILYd4, a Human CD59 Inhibitor Enhances Complement Dependent Cytotoxicity of Ofatumumab against Rituximab-resistant B-cell Lymphoma Cells and Chronic Lymphocytic Leukemia

Por Ge, Xiaowen, Wu, Lin, Hu, Weiguo, Fernandes, Stacey, Wang, Chun, Li, Xu, Brown, Jennifer R, Qin, Xuebin
Publicado em 2011

A case report of nodal CD4-positive T-cell lymphoproliferative disorder with an indolent course

Por Ge, Xiaowen, Zhu, Na, Yao, Jiamei, Zeng, Haiying, Su, Jieakesu, Jiang, Zhengzeng, Ji, Yuan, Tan, Yunshan, Hou, Yingyong
Publicado no Medicine (Baltimore) (2018)

The critical roles of platelet activation and reduced NO bioavailability in fatal pulmonary arterial hypertension in a murine hemolysis model

Por Hu, Weiguo, Jin, Richard, Zhang, Jinyan, You, Tao, Peng, Zhihai, Ge, Xiaowen, Bronson, Roderick T., Halperin, Jose A., Loscalzo, Joseph, Qin, Xuebin
Publicado em 2010

Tumor containing fragment number influences immunohistochemistry positive rate of HER2 in biopsy specimens of gastric cancer

Por Xu, Chen, Liu, Yalan, Ge, Xiaowen, Jiang, Dongxian, Zhang, Ying, Ji, Yuan, Hou, Jun, Huang, Jie, Su, Jieakesu, Zeng, Haiying, Qin, Jing, Hou, Yingyong
Publicado no Diagn Pathol (2017)

Poor efficacy response to trastuzumab therapy in advanced gastric cancer with homogeneous HER2 positive and non-intestinal type

Por Xu, Chen, Liu, Yalan, Jiang, Dongxian, Li, Qian, Ge, Xiaowen, Zhang, Ying, Huang, Jie, Su, Jieakesu, Ji, Yuan, Hou, Jun, Lu, Shaohua, Hou, Yingyong, Liu, Tianshu
Publicado no Oncotarget (2017)

Human CD59 inhibitor sensitizes rituximab resistant lymphoma cells to complement-mediated cytolysis

Por Hu, Weiguo, Ge, Xiaowen, You, Tao, Xu, Ting, Zhang, Jinyan, Wu, Gongxiong, Peng, Zhihai, Chorev, Michael, Aktas, Bertal H., Halperin, Jose A., Brown, Jennifer R, Qin, Xuebin
Publicado em 2011

Removal of the Tag from His-tagged ILYd4, a Human CD59 Inhibitor, Significantly Improves its Physical Properties and its Activity

Por Wu, Lin, Su, Sanbao, Liu, Fengming, Xu, Tao, Wang, Xiaoxiao, Huang, Yan, Sun, Xinlu, Ge, Xiaowen, Chen, Ting, Liu, Huixia, Wang, Chun, Chorev, Michael, Xu, Ting, Qin, Xuebin
Publicado no Curr Pharm Des (2012)